Forefront Wealth Partners, LLC Mereo Biopharma Group PLC Transaction History
Forefront Wealth Partners, LLC
- $397 Billion
- Q3 2025
A detailed history of Forefront Wealth Partners, LLC transactions in Mereo Biopharma Group PLC stock. As of the latest transaction made, Forefront Wealth Partners, LLC holds 33,180 shares of MREO stock, worth $60,387. This represents 0.02% of its overall portfolio holdings.
Number of Shares
33,180Holding current value
$60,387% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding MREO
# of Institutions
96Shares Held
99.9MCall Options Held
2.23MPut Options Held
179K-
Janus Henderson Group PLC London, X016.3MShares$29.6 Million0.02% of portfolio
-
Rubric Capital Management LP New York, NY15.3MShares$27.9 Million0.5% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA9.44MShares$17.2 Million0.79% of portfolio
-
Mangrove Partners New York, NY7.79MShares$14.2 Million1.99% of portfolio
-
Abrdn PLC5.54MShares$10.1 Million0.02% of portfolio
About Mereo Biopharma Group plc
- Ticker MREO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 124,986,000
- Market Cap $227M
- Description
- Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom and internationally. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the tr...